Conquering Diseases

A Study Looking At An Investigational Drug In Adults With Relapsing Multiple Sclerosis

Description

Seeking men and women 18 years of age or older with relapsing multiple sclerosis (RMS) for participation in a study comparing an investigational drug called fenebrutinib to a drug called teriflunomidie.

Overview

We are studying the effects of an investigational drug fenebrutinib and its safety for patients with RMS in comparison to teriflunomide.

What we're hoping for

To determine whether the effects of fenebrutinib versus teriflunomide provide benefits to patients with RMS

Additional Information

ClinicalTrials.gov Identifier: NCT04544449

 Principal Investigator

Carolina  Ionete, MD

UMass Memorial Health Care

 Study Contact

Mugdha  Deshpande

mugdha.deshpande@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989